About This Case

This website serves as a centralized, public record of an ongoing multi-forum legal dispute involving arbitration, federal court proceedings, and a Department of Labor whistleblower case.

The dispute involves a workforce structure connected, through multiple layers of entities, to major pharmaceutical companies including Sanofi, along with its affiliated entities Chattem and Quten Research Institute. According to the record, these relationships include the use of intermediary entities—managed through layered LLCs and private trust structures—with registered addresses tied to law firms, under which workers were placed while performing nationwide operations.


At its core, this case concerns an alleged system in which a nationwide workforce was placed under layers of entities—often tied to a single registered office address while the actual operations, product lines, and funding traced to larger upstream companies. Workers were engaged in selling nationally distributed consumer products, including those later involved in a reported $1.4 billion acquisition, yet were formally placed under entities that, at times, lacked registration in the states where the work occurred.

These entities were connected through layers of LLCs and private trusts, with addresses—such as 411 E. Bonneville Avenue in Las Vegas—appearing on employee paystubs despite not being operational workplaces. As a result, workers could not clearly identify their employer, who controlled their work, or where accountability ultimately resided. Workers describe being shifted between entities without notice, paid by companies they did not recognize, and lacking any meaningful path to address wage issues, retaliation, or workplace concerns.

The allegations focus on whether this structure was used to shift liability away from the entities benefiting from the work, while maintaining centralized control over operations. The significance of this case extends beyond a single dispute, it raises broader questions about how employment structures are defined, who is responsible when issues arise, and whether layered corporate arrangements can obscure accountability at scale.

The case is not confined to a single lawsuit. It is divided across multiple legal forums, each addressing different aspects of the same underlying facts and structure. This site brings those proceedings together in one place so the full record can be reviewed as a whole.


The Cases and How They Are Divided

This matter is currently proceeding across four primary forums:

  • Private Arbitration (JAMS) (DRVM)
    Addressing wage-related claims and the scope of arbitration (First filed February 19, 2025)
  • Federal Court (Petition to Compel Arbitration) (Closed)
    Addressed who could be required to participate in arbitration and what claims are included (First filed July 31, 2025)
  • Department of Labor Whistleblower Case (TFA / SOX)
    Addressing retaliation following protected disclosures under federal law (First filed August 2025; Notice of Docketing November 14, 2025; Notice of Hearing March 17, 2026)
  • Federal Fraud Civil Action
    Addressing fraud, misrepresentation, and enterprise-level conduct (First filed December 11, 2025)

Each proceeding involves overlapping facts, but no single forum contains the full picture on its own.

Who This Case Involves

The record reflects a workforce and product distribution system that has operated for over a decade, centered around retail demonstration programs in major stores such as Costco.

Beginning around 2012, workers were engaged in promoting consumer supplement products associated with Quten Research Institute, known for Qunol products (including CoQ10 and turmeric). The company is publicly associated with co-founders Ashraf Peter Boutros and Deepak Chopra.

Workers also promoted products associated with Zena Nutrition, including liquid collagen and supergreens formulations. That company is also associated with Ashraf Peter Boutros. And registered at the same address, 411 E. Bonneville Ave.

At the operational level, workforce management was associated with Maged Boutros, who was commonly known to workers as “Mike.”

In 2023, the Qunol-related business was acquired by Sanofi, a multinational pharmaceutical company, in a transaction reported at approximately $1.4 billion. Certain related entities and intellectual property were subsequently integrated into the structure of Chattem, a Sanofi subsidiary known for consumer healthcare products such as Icy Hot and Allegra.


Structure and Employment Model at Issue

A central issue in this case is how the workforce was structured and managed across entities.

Workers operated under the name “Direct Demo” while selling products like Qunol and Zena in retail environments. However, the entity listed as the employer on payroll records was often a separate company, such as DRVM LLC or similar entities.

The record reflects:

  • Workers being onboarded under one entity and paid through another
  • Changes in employer identity reflected in paystubs over time
  • Paystub addresses corresponding to registered offices rather than operational locations, including 411 E. Bonneville Ave. in Las Vegas
  • The use of multiple entities connected through layered LLCs and trust structures

In some instances, entities associated with the workforce were not registered in the states where employees were working at the time, or were associated with registered agent addresses rather than operational business locations.

The claims in this case examine whether this reflects independent entities operating separately—or a coordinated structure operating across multiple layers.


Corporate Structure and Changes During Litigation

The record also reflects changes in entity structure and registrations over time.

Following the initiation of disputes and litigation timelines, certain entities, such as DRVM LLC, began registering across multiple states where operations were occurring.

During this same period:

  • Control of certain entities was associated with Basil Management Trust
  • Steven S. Dickert was identified in roles connected to those entities
  • Additional entities were transferred or aligned with the Sanofi/Chattem structure
  • Registrations occurred in multiple phases, including coordinated filings on the same dates

These developments are part of the factual record being examined across the proceedings.


Purpose of This Site

The purpose of this website is to organize the record and make it accessible.

Specifically, it allows readers to:

  • Review filings, orders, and exhibits across all forums
  • Compare positions taken in different proceedings
  • Track timelines and procedural developments
  • Evaluate the record directly through primary source documents

This site does not ask anyone to rely on summaries alone.

It provides the true materials so the record can be reviewed independently. We are often lied to. You have to look for yourself.


What You’ll Find Here

  • Arbitration — filings, motions, and exhibits
  • Federal Court (Petition to Compel) — motions, declarations, and rulings
  • Federal Fraud Civil Case — complaint and ongoing filings
  • Department of Labor (TFA / SOX) — disclosures, orders, updates
  • Posts & Updates — ongoing case developments
  • Parties & Entities — structured reference guide
  • Contact — media, legal, or documentation requests

Why This Matters

Because this case is split across multiple systems, the record is fragmented.

Positions may differ across forums.

Documents may appear in one proceeding but not another.

Key issues may be addressed in isolation.

This site allows the record to be viewed as a whole.


Who Runs This Site

My name is Jorden Hollingsworth.

I am the whistleblower and a pro se litigant in the matters referenced on this site.

I created this platform to organize the record, preserve transparency, and ensure that filings across different forums can be reviewed together rather than in isolation.

For additional background, see the Whistleblower page.